HF & APO Group 5 Year 5 2012
-
Upload
topper1101 -
Category
Documents
-
view
217 -
download
0
Transcript of HF & APO Group 5 Year 5 2012
-
8/2/2019 HF & APO Group 5 Year 5 2012
1/38
RADIOLOGY
HEARD FAILURE
PULMONARY EDEMA
Year 5 Group 5, 2011/2012
-
8/2/2019 HF & APO Group 5 Year 5 2012
2/38
CONGESTIVE HEART FAILURE
Introduction
Congestive heart failure (CHF) is the result ofinsufficient output because ofcardiac failure,high resistance in the circulation or fluid
overload. Causes of CHF Coronary artery disease
Hypertension
Cardiomyopathy
Cardiac valvular lesions Arrhythmias
Hyperthyroidism
Severe anemia
Left to right shunts
-
8/2/2019 HF & APO Group 5 Year 5 2012
3/38
CONGESTIVE HEART FAILURE
Introduction
Left ventricle (LV) failure
Most common and results in decreased cardiacoutput and increased pulmonary venous
pressure.In the lungs, LV failure will lead to dilatation ofpulmonary vessels, leakage of fluid into theinterstitium and the pleural space and finallyinto the alveoli resulting in pulmonary edema.
Right ventricle (RV) failureUsually the result of long standing LV failure or
pulmonary disease and causes increasedsystemic venous pressure resulting in edema independent tissues and abdominal viscera.
-
8/2/2019 HF & APO Group 5 Year 5 2012
4/38
CONGESTIVE HEART FAILURE
Clinical Features1. Left Heart Failure
Shortness of breath
Paroxysmal nocturnal dypsnea
Orthopnea
Cough
2. Right Heart Failure
Edema
-
8/2/2019 HF & APO Group 5 Year 5 2012
5/38
CONGESTIVE HEART FAILURE
Illustration of features in CHF
-
8/2/2019 HF & APO Group 5 Year 5 2012
6/38
CONGESTIVE HEART FAILURE
Pathophysiology of CHF
Left Ventricular Failure
CO decreases and pulmonary venous pressure increases
Pulmonary capillary pressure exceeds the oncotic pressure of plasma proteins
Fluid accumulates in and around the capillaries in the interlobular septa
Further accumulation occurs in interstitial tissues of the lungs
Finally with increasing fluids alveolar fill with edema fluid
-
8/2/2019 HF & APO Group 5 Year 5 2012
7/38
CONGESTIVE HEART FAILURE
-
8/2/2019 HF & APO Group 5 Year 5 2012
8/38
Stage I : Redistribution
1. Redistribution of pulmonary blood flow
2. Increase in width of the vascular pedicle
3. Increased artery-to-bronchus ratio in the
upper and middle lobes
4. Cardiomegaly
5. Dilatation of azygos vein
-
8/2/2019 HF & APO Group 5 Year 5 2012
9/38
Stage I Redistribution
Redistribution of pulmonary blood flow
Views of the upper lobe vessels of a patient in good condition
(left) and during a period of CHF (right). Notice also the increased
width of the vascular pedicle (red arrows).
-
8/2/2019 HF & APO Group 5 Year 5 2012
10/38
Bordered on the right by the superior vena
cava and on the left by the left subclavian
artery origin
Indicator of the intravascular volume
-
8/2/2019 HF & APO Group 5 Year 5 2012
11/38
Stage I Redistribution
Increased artery-to-bronchus ratio in the upper and middle
lobes (normal 0.85)
On the left a patient with cardiomegaly and redistribution.
The upper lobe vessels have a diameter > 3 mm (normal 1-2 mm).
Notice the increased artery-to-bronchus ratio at hilar level (arrows).
-
8/2/2019 HF & APO Group 5 Year 5 2012
12/38
Stage I Redistribution
Cardiomegaly (Cardiothoracic ratio, CTR)
Ratio of the transverse diameter of the heart to the
internal diameter of the chest at its widest point just
above the dome of the diaphragm
Cardiomegaly CTR is > 50%
a
bc
-
8/2/2019 HF & APO Group 5 Year 5 2012
13/38
Stage I Redistribution
Dilatation of azygos vein (Sign of increased right atrial pressure )
Standing position - > 7 mm is most likely abnormal & a
diameter > 10 mm is definitely abnormal.
Supine patient > 15 mm is abnormal
-
8/2/2019 HF & APO Group 5 Year 5 2012
14/38
Stage II: Pulmonary interstitial edema
4 key radiographic signs
a) Thickening of the interlobular septa
(Kerley-B, Kerley-A)
b) Peribronchial cuffing
c) Fluid in the fissures
d) Pleural effusions
-
8/2/2019 HF & APO Group 5 Year 5 2012
15/38
a) Thickening of the interlobular
septa: The Kerley B line
B = distended interlobular septa
Location and appearance
Bases 1-2 cm long
Horizontal in direction
Perpendicular to pleural surface
-
8/2/2019 HF & APO Group 5 Year 5 2012
16/38
Kerley A line
A = connective tissue near bronchoarterial
bundle distends
Location and appearance
Near hilum
Run obliquely
Longer than B lines
-
8/2/2019 HF & APO Group 5 Year 5 2012
17/38
Kerley B lines (red arrows)
Kerley A lines (yellow arrows)
-
8/2/2019 HF & APO Group 5 Year 5 2012
18/38
Kerley B lines (red arrows)
Kerley A lines (yellow arrows)
-
8/2/2019 HF & APO Group 5 Year 5 2012
19/38
Kerley C = reticular network of lines
-
8/2/2019 HF & APO Group 5 Year 5 2012
20/38
b) Peribronchial cuffing
Interstitial fluid accumulates
around bronchi
Causes thickening of bronchial wall
When seen on end, looks like little
doughnuts
-
8/2/2019 HF & APO Group 5 Year 5 2012
21/38
Peribronchialcuffing appears
as numerous,
small, ringlike
shadows that
look like little
doughnut
-
8/2/2019 HF & APO Group 5 Year 5 2012
22/38
c) Fluid in the fissures
Fluid may collects in the subpleural space
which is between visceral pleura and lung
parenchyma
Normal fissure is thickness of a sharpened
pencil line
Fluid may collect in any fissure including
major(horizontal), minor(oblique),
accessory fissures, azygous fissure
-
8/2/2019 HF & APO Group 5 Year 5 2012
23/38
-
8/2/2019 HF & APO Group 5 Year 5 2012
24/38
-
8/2/2019 HF & APO Group 5 Year 5 2012
25/38
d) Pleural effusion
As a result of either increasedproduction or decreased absorptionof pleural fluid, fluid in excess of 2-5ml can collect in the pleural space,
typically at a pulmonary capillarywedge pressure of 20 mmHg.
Features of pleural effusion: Subpulmonic effusion
Blunting of costophrenic angles Meniscal sign
Opacified hemithorax
-
8/2/2019 HF & APO Group 5 Year 5 2012
26/38
Subpulmonic effusion
Fluid is first collected in area beneath the lung btw theparietal pleura lining the sup. surface of diaphragm andthe visceral pleura under the lower lobe
-
8/2/2019 HF & APO Group 5 Year 5 2012
27/38
-
8/2/2019 HF & APO Group 5 Year 5 2012
28/38
-
8/2/2019 HF & APO Group 5 Year 5 2012
29/38
Stage III: Pulmonary alveolar
edema
When pulmonary venous pressure
is sufficiently elevated (about 25mmHg), fluid spills out of the
interstitial tissues of the lung into
the airspaces.
This results in pulmonary edema
-
8/2/2019 HF & APO Group 5 Year 5 2012
30/38
Fluffy, indistinct,patchy airspacedensities that are
usually centrallylocated.
Outer third of thelung is usuallyspared, and the LZ> UZ, giving rise tobat-wing, angelwing or butterflyconfiguration of
pulmonary edema Presence of pleural
effusion(cardiogenic)
-
8/2/2019 HF & APO Group 5 Year 5 2012
31/38
-
8/2/2019 HF & APO Group 5 Year 5 2012
32/38
-
8/2/2019 HF & APO Group 5 Year 5 2012
33/38
Classification
Pulmonaryedema
Cardiogenic
Pulmonaryinterstitialedema
Pulmonaryalveolaredema
Non-cardiogenic
- ARDS
- V. Overload
- Malignancy
PULMONARY EDEMA
-
8/2/2019 HF & APO Group 5 Year 5 2012
34/38
NON-CARDIOGENIC
PULMONARY EDEMA
1. Increase capillary permeability Acute Respiratory Distress Syndrome (ARDS)
Sepsis
Uremia
DIC
Smoke inhalation
Near drowning
2. Volume overload
3. Lymphangitic spread of malignancy
4. Others High-altitude pulmonary edema
Neurogenic pulmonary edema
Reexpansion pulmonary edema
Heroin or other overdose
-
8/2/2019 HF & APO Group 5 Year 5 2012
35/38
NON-CARDIOGENIC
PULMONARY EDEMA
The vascular pedicle width (VPW) can help in differentiatingthese different forms of pulmonary edema (6):
Normal VPW: most common in capillary permeability or
acute cardiac failure.
Widened VPW: most common in overhydration/renal failure
and chronic cardiac failure.
Narrowed VPW: most common in capillary permeability.
Other features
less demonstrate pleural effusion and Kerley B line
normal heart sizemore patchy and peripheral
-
8/2/2019 HF & APO Group 5 Year 5 2012
36/38
NON-CARDIOGENIC
PULMONARY EDEMA
On the left a patient with
ARDS.
There is alveolar edema inboth lungs.
Notice that the VPW is
normal.
The vessels in the upper
lobes are not dilated and nocardiomegaly.
-
8/2/2019 HF & APO Group 5 Year 5 2012
37/38
Chest radiograph
shows bilateral
perihilar airspace
shadowing with
normal heart size
and no pleural
effusion.
-
8/2/2019 HF & APO Group 5 Year 5 2012
38/38